GPT Healthcare Limited (NSE:GPTHEALTH)
India · Delayed Price · Currency is INR 143.13
+0.73 (0.51%)
Jun 1, 2026, 3:29 PM IST
GPT Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 4,725 | 4,071 | 4,002 | 3,610 | 3,374 | |
Revenue Growth (YoY) | 16.08% | 1.72% | 10.85% | 7.00% | 39.00% |
Cost of Revenue | 1,742 | 1,644 | 1,648 | 1,511 | 1,534 |
Gross Profit | 2,984 | 2,427 | 2,354 | 2,100 | 1,840 |
Selling, General & Admin | - | 93.68 | 59.97 | 65.87 | 42.12 |
Other Operating Expenses | 2,142 | 1,499 | 1,411 | 1,290 | 1,058 |
Operating Expenses | 2,413 | 1,783 | 1,651 | 1,505 | 1,236 |
Operating Income | 570.95 | 643.23 | 703.45 | 594.4 | 604.51 |
Interest Expense | -82.4 | -25.3 | -64.95 | -84.43 | -101.94 |
Interest & Investment Income | - | 48.75 | 36.04 | 38.8 | 39.73 |
Other Non Operating Income (Expenses) | 59.51 | 4.69 | -1.22 | -2.98 | -5.91 |
EBT Excluding Unusual Items | 548.06 | 671.38 | 673.32 | 545.79 | 536.39 |
Gain (Loss) on Sale of Investments | - | 4.01 | 2.9 | 1.79 | 1.93 |
Gain (Loss) on Sale of Assets | - | 1.84 | -2.03 | 4.51 | -1.14 |
Asset Writedown | - | 1.5 | 1.01 | - | 1.13 |
Other Unusual Items | - | 14.73 | 5.24 | 7.61 | 2.48 |
Pretax Income | 548.06 | 693.46 | 680.43 | 559.69 | 540.79 |
Income Tax Expense | 125.85 | 194.24 | 202.74 | 169.62 | 124.16 |
Net Income | 422.21 | 499.22 | 477.69 | 390.08 | 416.63 |
Net Income to Common | 422.21 | 499.22 | 477.69 | 390.08 | 416.63 |
Net Income Growth | -15.43% | 4.51% | 22.46% | -6.37% | 97.52% |
Shares Outstanding (Basic) | 82 | 82 | 80 | 80 | 80 |
Shares Outstanding (Diluted) | 82 | 82 | 80 | 80 | 80 |
Shares Change (YoY) | -0.09% | 2.44% | 0.24% | - | - |
EPS (Basic) | 5.15 | 6.08 | 5.96 | 4.88 | 5.21 |
EPS (Diluted) | 5.15 | 6.08 | 5.96 | 4.88 | 5.21 |
EPS Growth | -15.30% | 2.01% | 22.13% | -6.33% | 97.36% |
Free Cash Flow | 393.42 | 174.71 | 494.33 | 565.24 | 586.96 |
Free Cash Flow Per Share | 4.80 | 2.13 | 6.17 | 7.07 | 7.35 |
Dividend Per Share | 2.500 | 2.500 | 2.500 | 4.000 | - |
Dividend Growth | - | - | -37.50% | - | - |
Gross Margin | 63.15% | 59.61% | 58.83% | 58.16% | 54.55% |
Operating Margin | 12.08% | 15.80% | 17.58% | 16.46% | 17.92% |
Profit Margin | 8.94% | 12.26% | 11.94% | 10.80% | 12.35% |
Free Cash Flow Margin | 8.33% | 4.29% | 12.35% | 15.66% | 17.40% |
EBITDA | 841.83 | 770.94 | 831.82 | 715.61 | 724.06 |
EBITDA Margin | 17.82% | 18.94% | 20.79% | 19.82% | 21.46% |
D&A For EBITDA | 270.88 | 127.72 | 128.37 | 121.21 | 119.55 |
EBIT | 570.95 | 643.23 | 703.45 | 594.4 | 604.51 |
EBIT Margin | 12.08% | 15.80% | 17.58% | 16.46% | 17.92% |
Effective Tax Rate | 22.96% | 28.01% | 29.80% | 30.30% | 22.96% |
Revenue as Reported | 4,785 | 4,156 | 4,055 | 3,667 | 3,424 |
Advertising Expenses | - | 78.63 | 41.43 | 50.5 | 26 |